Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
How the Muscle Spasticity Market Has Progressed: A Look Back Over the Past Few Years?
The market for muscle spasticity treatments has seen robust growth over the past few years. The sector, whose value stood at $4.19 billion in 2024, is projected to expand to $4.57 billion in 2025, reflecting a Compound Annual Growth Rate (CAGR) of 9.1%.
This growth during the previous years can be linked to higher investment in R&D, a rise in clinical indications, encouraging regulatory green lights and reimbursement strategies, a growing focus on a multimodal focussed approach, and a rise in cases of multiple sclerosis.
Anticipations are high for the muscle spasticity market to experience significant expansion in the upcoming years. It is believed that the market will have a compound annual growth rate (CAGR) of 8.8%, reaching a $6.41 billion valuation by 2029.
Factors contributing to this expected growth include an increasing focus on creating patient-focused care models, broadening of distribution networks, emphasis on enhancing the quality of life, continuous development of specific drug delivery systems, and the finding of biomarkers. Key trends influencing this growth forecast involve the use of value-based reimbursement models, incorporation of AI and machine learning technologies, adoption of telehealth and remote health monitoring technology, employing neurostimulation techniques, and the application of regenerative medicine strategies.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What’s Driving the Upward Growth Trajectory of the Muscle Spasticity Market?
The muscle spasticity market is anticipated to grow due to the escalating cases of musculoskeletal ailments. These illnesses are conditions that impact the body’s muscles, bones, and joints, often leading to pain, stiffness, and movement restrictions.
The surge in such occurrences is connected to factors such as the aging populace, inactive lifestyles, and the escalating cases of chronic disorders.
Muscle spasticity’s objective is to mitigate the symptoms of musculoskeletal conditions by decreasing pain, enhancing mobility, averting complications, and improving patients’ overall life quality and functional capabilities.
For example, The Lancet, a medical journal based in the UK, conducted a study in November 2023. The study found that around 494 million people around the world experienced other musculoskeletal conditions in 2020, with forecasts suggesting a possible 115% surge by 2050.
Furthermore, Amgen, a biopharmaceutical firm located in the US, stated in May 2022 that the annual count of fractures due to osteoporosis is set to increase by 68%, from 1.9 million in 2018 to 3.2 million in 2040. Therefore, the escalating cases of musculoskeletal ailments are propelling the muscle spasticity market.
Which Segments in the Muscle Spasticity Industry Are Seeing the Fastest Growth?
The muscle spasticity market covered in this report is segmented –
1) By Drug Type: Baclofen, Botulinum Toxin, Diazepam, Dantrolene Sodium, Other Drugs
2) By Route Of Administration: Oral, Intramuscular, Other Routes
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Baclofen: Oral Baclofen, Intrathecal Baclofen (Pump)
2) By Botulinum Toxin: Botox (Botulinum Toxin Type A), Dysport (Botulinum Toxin Type A), Xeomin (Botulinum Toxin Type A), Myobloc (Botulinum Toxin Type B)
3) By Diazepam: Oral Diazepam, Injectable Diazepam
4) By Dantrolene Sodium: Oral Dantrolene, Injectable Dantrolene
5) By Other Drugs: Tizanidine, Clonidine, Gabapentin, Other Muscle Relaxants, Selective Serotonin Reuptake Inhibitors (SSRIs)
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
How Will Shifting Market Trends Influence Muscle Spasticity System Adoption?
Key corporations in the muscle spasticity market are prioritizing the creation of oral suspensions to manage muscle spasms linked with ailments like multiple sclerosis and spinal cord injuries. Oral suspensions are liquid drugs with distributed active compounds that are ingested orally.
As an example, ANI Pharmaceuticals, an American pharmaceutical manufacturing firm, introduced baclofen oral suspension in April 2024. Baclofen oral suspension, a generic counterpart of fleqsuvy, aids in muscle relaxation to alleviate spasms caused by conditions such as multiple sclerosis and spinal cord injuries.
Which Global Regions Are Powering Demand in the Muscle Spasticity Market?
North America was the largest region in the muscle spasticity market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The regions covered in the muscle spasticity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
How Key Players Are Driving Growth in the Muscle Spasticity Market?
Major companies operating in the muscle spasticity market are F. Hoffmann-La Roche AG, AbbVie Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Neurocrine Biosciences Inc., Merz Pharmaceuticals GmbH, Beximco Pharmaceuticals Ltd., ANI Pharmaceuticals Inc., Taj Pharmaceuticals Limited, Revance Therapeutics Inc., Acorda Therapeutics Inc., Mylan N.V., Camber Pharmaceuticals Inc., Saol Therapeutics Inc., Zydus Cadila
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=18411
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
